基于人群的队列研究:利用粪便免疫化学检测、血液结果和患者特征对威尔士有症状患者进行结直肠癌风险分层
威尔士一项基于人群的队列研究纳入166,863例有症状并接受FIT检测的患者,发现FIT≥10 μgHb/g者1年内结直肠癌风险超过3%,且合并缺铁性贫血可进一步分层,尤其在50岁以下女性中风险显著升高。
要点
- FIT≥10 μgHb/g在威尔士有症状人群中1年CRC风险>3%,高于英格兰和苏格兰队列。
- 合并缺铁性贫血可提高FIT≥10 μgHb/g者的预测风险,50岁以下女性分层意义显著。
- demographics和血液结果可识别最高危人群,但未完全解释威尔士基线风险较高。
核心结论
- 威尔士有症状患者FIT≥10 μgHb/g后1年CRC风险高于英格兰和苏格兰观察值。
- 按人口学和血液结果分层可识别最高危人群,但未完全解释威尔士较高基线风险。
研究设计与样本
- 基于威尔士纵向全科医疗数据集成年人的队列研究。
- 纳入2020年1月1日至2024年3月31日有FIT记录的成人,共166,863例。
- 使用Kaplan-Meier法计算1年累积CRC风险。
主要发现
- 19.2%的患者FIT≥10 μgHb/g。
- 1年内2864例(1.72%)诊断为CRC,其中90.2%发生在FIT≥10 μgHb/g之后。
- FIT≥10 μgHb/g单独在所有年龄组均识别出>3%的CRC风险。
- FIT≥10 μgHb/g者合并IDA时所有年龄组预测风险增加。
- 50岁以下女性FIT≥10 μgHb/g合并IDA的CRC风险为6.45%(95%CI 3.52-9.29),无IDA为2.20%(95%CI 1.57-2.83)。
关键数值与推荐
- FIT≥10 μgHb/g在有症状患者中提示CRC风险>3%。
- FIT≥10 μgHb/g合并IDA时风险进一步升高,50岁以下女性尤为显著。
临床怎么用
- 对有症状患者使用FIT≥10 μgHb/g识别CRC高风险人群。
- 结合人口学特征和IDA结果进行风险分层,尤其关注50岁以下女性。
- 威尔士背景下FIT≥10 μgHb/g的风险阈值可能需考虑本地较高基线风险。
局限性
- 未完全解释威尔士与其他英国地区基线风险差异的原因。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Wales has the highest rate of colorectal cancer (CRC) in the UK. National guidelines recommend using the faecal immunochemical test (FIT) in patients presenting with symptoms of bowel cancer. FIT ≥ 10 μgHb/g in symptomatic patients is presumed to indicate a > 3% risk of CRC. However, evidence from England and Scotland has found that the risk is lower in certain demographic groups. AIMS: To examine 1-year risk of CRC in Welsh patients with symptoms of suspected bowel cancer by demographics, iron deficiency anaemia (IDA), and FIT. METHODS: Cohort study of adults registered in the Welsh Longitudinal General Practice dataset with a FIT recorded from 01/01/2020-31/03/2024. Kaplan-Meier estimates were used to calculate 1-year cumulative risks of CRC. RESULTS: We included 166,863 patients with a FIT; 19.2% had a FIT ≥ 10 μgHb/g. Within 1 year, 2864 (1.72%) were diagnosed with CRC; 90.2% of which were following FIT ≥ 10μgHb/g. A FIT cut-off of ≥ 10 μgHb/g in isolation identified a > 3% risk of CRC across all age groups. In those with FIT ≥ 10μgHb/g, IDA resulted in an increase in predicted risk across all age groups. IDA aided stratification further in women < 50 years; risk of CRC was 6.45% (95% CI: 3.52-9.29) with a FIT ≥ 10 μgHb/g and IDA compared to 2.20% (95% CI: 1.57-2.83) without IDA. CONCLUSIONS: In Wales, the risk of CRC following FIT ≥ 10 μgHb/g is higher than observed in English and Scottish cohorts. Stratification by demographics and blood results identified those at highest risk, but this did not fully explain the higher baseline risk observed in comparison to other UK nations.
引用
- Malcolm FL, Crooks CJ, West J, et al. Population-Based Cohort Study: Colorectal Cancer Risk Stratification in Symptomatic Patients Using the Faecal Immunochemical Test, Blood Results and Patient Characteristics in Wales. Aliment Pharmacol Ther. 2026. PMID: 42855887. doi:10.1111/apt.71028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。